ReviveMed's technology uses artificial intelligence-based analysis of metabolomics data for drug discovery and development.
In a training subset of the larger cohort, the company was able to develop classifiers that detected many cancers while minimizing false positives.
The award expands an existing collaboration between the firms for automated organism design.
Through their partnership, Genomenon and Veritas Genetics hope to develop a new literature prioritization engine to bring down the cost of WGS interpretation.
The firm said it will use the funding to consolidate its position in clinical diagnostics, establish a US office, and enter new diagnostic markets.
As part of a collaboration with Freenome, Institut Curie will look for correlations between circulating biomarkers and human response to cancer immunotherapies.
As genomics increasingly becomes a part of healthcare, more diverse datasets will be needed to avoid biases in algorithms used to analyze data and make diagnoses.
At HIMSS18, Eric Schmidt announced a new healthcare API for Google Cloud and explored how predictive analytics might change medical care and research for the better.
The Israeli molecular diagnostics company will use artificial intelligence and phenotypic analysis to increase the diagnostic rate of its genetic tests.
Startup Optra Health has added Alexa and Cortana compatibility to its AI platform to help consumers understand Ancestry.com- and 23andMe-type genetic tests.
In a cartoon, Vox explores the lack of women among this year's winners of the Nobel Prize.
Science reports a new US defense bill would establish two groups aimed at combating foreign influence on research.
Nature Biotechnology discusses promising early results from two clinical trials of CRISPR-based therapy for β-thalassemia and sickle cell disease.
In Cell this week: analysis of tissue clones, metagenomic studies of ocean water samples, and more.